Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Explore clinician-guided lipotropic injection therapy with transparent pricing, online provider review, and licensed pharmacy fulfillment
Mechanism of Action: Triple Receptor Agonist Retatrutide is a synthetic peptide that activates three key metabolic receptors: GLP-1 (Glucagon-Like Peptide-1) Enhances insulin secretion, suppresses appetite, delays gastric emptying GIP (Glucose-Dependent Insulinotropic Polypeptide) Boosts insulin response, improves insulin sensitivity, may support lipid metabolism Glucagon Receptor (GCGR) Elevates energy expenditure, promotes fat oxidation, and may reduce liver fat This triple agonist profile delivers synergistic effects on glycemic control, fat loss, and metabolic health, making Retatrutide the most advanced incretin-based peptide in development
TB-500, a synthetic fragment derived from thymosin beta-4, has been studied for its role in cellular migration, cytoskeletal organization, angiogenesis, and tissue regeneration
Unlike Sermorelin, BPC 157 is not primarily a hormone-modulating peptide
